An initial study showed that TRPM8 was required for PCa survival (84), but subsequent studies found that both TRPM8 agonists (85) and antagonists (86) might have an antitumor effect in PCa, requiring further research to clarify. Here, TRPM8 is linked to posterior cortical atrophy.